GLI1 and cancer: Conversely, the silencing of GLI or OPN reversed EMT by reducing mesenchymal markers and increasing epithelial marker (keratin 18) expression, decreased ABCB1 and ABCG2 expression, and restored chemosensitivity to cancer chemotherapeutics [126].